Evidence map›Paper›PMID 35577937›Full record

ArticleEuropean journal of human genetics : EJHG2022

Perceptions of causal attribution and attitudes to genetic testing among people with schizophrenia and their first-degree relatives.

Melissa B R Cullen, Bettina Meiser, Kristine Barlow-Stewart, Melissa Green, Paul S Appelbaum, Vaughan J Carr, Murray J Cairns, M S Lebowitz, Rajneesh Kaur

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Happy 30th birthday to the European Journal of Human Genetics!European journal of human genetics : EJHG · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Melissa B R Cullen *School of Medicine, University of New South Wales, Sydney, Australia.
Bettina Meiser *Prince of Wales Clinical School, University of New South Wales, Sydney, Australia. b.meiser@unsw.edu.au.ORCID 0000-0002-5086-0784
Kristine Barlow-StewartSydney Medical School, University of Sydney, Sydney, Australia.
Melissa GreenSchool of Psychiatry, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID 0000-0002-9361-4874
Paul S AppelbaumDepartment of Psychiatry, Columbia University Vagelos College of Physicians & Surgeons, New York, USA.
Vaughan J CarrSchool of Psychiatry, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID 0000-0002-8907-5804
Murray J CairnsSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia.
M S LebowitzDepartment of Psychiatry, Columbia University Vagelos College of Physicians & Surgeons, New York, USA.
Rajneesh KaurSchool of Medicine, University of New South Wales, Sydney, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid advances in the genetics of psychiatric disorders mean that diagnostic and predictive genetic testing for schizophrenia risk may one day be a reality. This study examined how causal attributions for schizophrenia contribute to interest in a hypothetical genetic test. People with schizophrenia and first-degree relatives of people with schizophrenia were recruited through a schizophrenia research bank and mental health organisation. Semi-structured telephone interviews were conducted with 13 individuals with schizophrenia and 8 first-degree relatives. Transcripts were subjected to a qualitative analysis using the thematic analysis framework. Five themes were developed: (i) "It is like a cocktail", with most participants aware that both genetic and environmental factors contributed to causation, and many mentioning the positive impact of genetic causal explanations; (ii) "Knowledge is power" (i.e., in favour of genetic testing); (iii) Genetic testing provides opportunities for early intervention and avoiding triggers, with participants citing a wide range of perceived benefits of genetic testing but few risks; (iv) Views on reproductive genetic testing for schizophrenia risk with a few participants viewing it as "playing God" but not necessarily being against it; and (v) "It snowballs", whereby participants' understanding of genetics was sophisticated with most believing that multiple rather than single genes contributed to schizophrenia. In conclusion, many individuals had a sound understanding of the role of genetic testing if it were to become available, with evidence of insight into the role of multiple genes and the contribution of other risk factors that may interact with any inherited genetic risk.

Indexed as

SchizophreniaAttitudeAwarenessGenetic TestingHumansRisk Factors

Identifiers

PMID35577937
PMCPMC9553941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.